drugset / Trial / NCT00358410

An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia

NCT00358410

Phase 2 Completed 13 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This study was designed is to examine the idea that GW679769 has an effect on three of the pathophysiological disturbances reported in patients with Functional Dyspepsia (FD): impaired stomach accommodation to a meal, delayed stomach emptying, and visceral hypersensitivity to distension.

Timeline

Start
2006-01
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Casopitant Small molecule 120 mg Oral

Indications